Eagerly awaited results show for the first time, from a prospective trial, that women with multiple breast cancer foci can safely undergo breast-conserving therapy, with low local recurrence rates.
Overall, the study highlights the efficacy of lumpectomy plus radiation as an alternative to mastectomy for recurrent disease. The study was published as a preprint and has not yet been peer reviewed.
A new study suggests that oncologists can safely pull back on standard locoregional radiotherapy in select patients with cT1-2N1 breast cancer who are treated with primary chemotherapy prior to surgery.
Older patients with low-grade, luminal A-type breast cancer may only need endocrine therapy following breast-conserving surgery and could avoid radiation therapy entirely.
The inframammary breast-conserving approach for deep-seated tumors led to acceptable cosmetic results in 82% of cases. The study was published as a preprint and has not yet been peer reviewed.